FilingReader Intelligence

Huahai Pharmaceutical offers third convertible bond put-back opportunity

December 17, 2025 at 10:39 AM UTCBy FilingReader AI

Zhejiang Huahai Pharmaceutical Co., Ltd. has issued a third announcement regarding the optional put-back for its "Huahai convertible bonds." The put-back price is 100.30 yuan per bond, inclusive of accrued interest and tax. The put-back period is scheduled from December 22, 2025, to December 26, 2025, with funds to be distributed on December 31, 2025. During this period, "Huahai convertible bonds" will cease to be convertible into shares, though trading will continue.

The put-back option was triggered as the company's stock price closed below 70% of the current conversion price for 30 consecutive trading days between November 2, 2025, and December 12, 2025, in accordance with the Convertible Bond Prospectus. Holders have the option to put back all or part of their unconverted bonds, but the exercise is not mandatory.

Investors are advised that electing to put back their bonds at 100.30 yuan per bond might result in losses, as the closing price of "Huahai convertible bonds" on the last trading day before this announcement exceeded the put-back price. If the total outstanding face value of the convertible bonds falls below 30 million yuan due to the put-back, trading will eventually cease after a three-day announcement period.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600521Shanghai Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →